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ABSTRACT
Objectives: To determine the efficacy of the physio-
logical ICSI technique (PICSI) vs. conventional ICSI in the 
prognosis of couples with male factor, with respect to the 
following outcome measures: live births, clinical pregnan-
cy, implantation, embryo quality, fertilization and miscar-
riage rates.
Methods: A systematic review of the literature, ex-
tracting raw data and performing data analysis. Patient(s): 
Couples with the male factor, who were subjected to in-vi-
tro fertilization. Main Outcome Measures: rates of live 
births, clinical pregnancy, implantation, embryo quality, 
fertilization and miscarriage.
Results: In the systematic search, we found 2,918 
studies and an additional study from other sources; only 
two studies fulfilled the inclusion criteria for this systematic 
review. The rates of live births, clinical pregnancy, implan-
tation, embryo quality, fertilization and miscarriage were 
similar for both groups.
Conclusion: There is no statistically significant differ-
ence between PICSI vs. ICSI, for any of the outcomes ana-
lyzed in this study. Enough information is still not available 
to prove the efficacy of the PICSI technique over ICSI in 
couples with male factor.
Keywords: PICSI, physiological ICSI, hyaluronic acid, HA 
sperm selection, male factor
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INTRODUCTION
Age, associated pathologies, geographic location, con-
sumption of alcohol, tobacco and other drugs, exposure 
to environmental and chemical contaminants, body and 
environmental temperatures, are some of the causes of 
male infertility (Gao et al., 2007; He et al., 2015; Imai et 
al., 2010; Verratti et al., 2008; Zou et al., 2011). Present-
ly, the way to evaluate a semen sample is through direct 
spermatobioscopy, a descriptive tool that does not evalu-
ate damage in sperm DNA (Morales et al., 2007; Espino-
za-Navarro et al., 2010; World Health Organization, 2010; 
Cooper et al., 2010; González Ravina & Pacheco Castro, 
2011). It is known that defects in genetic material, such 
as anomalies in chromatin condensation with respect to 
the sperm maturation process, the integrity of the DNA 
molecule in conjunction with the presence of DNA double 
chain ruptures, as well as in the single DNA chain, or the 
presence of chromosomal anomalies, are all related to in-
fertility (Cortes-Gutiérrez et al., 2007). Oocytes are capa-
ble of repairing sperm damage, depending on the type of 
damage that is present in the spermatozoa (Castillo-Baso 
& García-Villafaña, 2012).
Diverse techniques have been developed for assisted 
reproduction to increase pregnancy likelihoods. One of 
the most used techniques is the intracytoplasmic sperm 
injection or conventional ICSI. However, in this tech-
nique sperm selection is subjective, since the embry-
ologist chooses, under his/her criterion, which are the 
best spermatozoa seen at low resolution, thus eliminat-
ing the process of natural selection. There is a great-
er risk of congenital defects and miscarriages, since it 
is impossible to know whether the chosen spermato-
zoa have alterations in their nucleus or if there is DNA 
fragmentation (Castillo-Baso & García-Villafaña, 2012; 
González-Ortega et al., 2010).
Hence, the physiological ICSI technique arose (PICSI - 
physiologically selected intracytoplasmic sperm injection). 
This technique is based on the fact that the mature sperm 
head has a specific receptor that allows it to bind to hyal-
uronic acid (HA), the main component of the cumulus oo-
phorous; this is in contrast to the immature spermatozoa, 
which do not have this ability to bind to HA. (Castillo-Baso 
& García-Villafaña, 2012; González-Ortega et al., 2010). 
It has been shown that spermatozoa that bind to HA have 
completed the spermatogenic process of remodeling the 
plasmatic membrane, cytoplasmic extrusion and nuclear 
maturity. Thus, they have a whole DNA and low frequency 
of aneuploidies and miscarriages. In this way, the genom-
ic contribution of the spermatozoa to the zygotes can be 
compared to that of the spermatozoa that are selected by 
the cumulus oophorous during natural fertilization (Castil-
lo-Baso & García-Villafaña, 2012; González-Ortega et al., 
2010). PICSI has previously shown satisfactory results in 
diverse study groups, where the male factor was present 
and where the influence of sperm DNA fragmentation on 
reproduction techniques has been described (Castillo-Baso 
& García-Villafaña, 2012; Gongora-Rodriguez & Fontanil-
la-Ramirez, 2010; Parmegiani et al., 2010a; Majumdar & 
Majumdar, 2013). Nevertheless, they suggest doing fur-
ther studies to this respect.
The objective of this systematic review is to determine 
the efficacy of the PICSI technique vs. the ICSI in the 
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prognosis of couples with male factor, with respect to the 
following outcome measures: live births, clinical pregnan-





A controlled search for clinical trials was carried out, 
in English and Spanish, up to August of 2015, including 
the following MeSH terminology: "male infertility"; "male 
factor"; "ICSI"; "PICSI"; "Physiological ICSI"; "Intracyto-
plasmic Sperm Injection"; "Physiological Intracytoplasmic 
Sperm Injection"; "hyaluronic acid"; "HA sperm selection".
Type of participants
Couples with the male factor, comparing PICSI vs. 
ICSI. Studies which did not fulfill the inclusion criteria were 
taken off the search.
Type of intervention
The intervention of interest for this study is the sys-
tematic review of the literature, extraction of raw data and 
data analyses.
Outcome measures
The primary outcomes of this systematic review were: 
miscarriage, live births and clinical pregnancy. Secondary 
outcomes were: implantation, embryo quality and fertil-
ization.
Search methods and selection of studies
Electronic search
The PICO (Santos et al., 2007) method was used to 
construct the research question and the bibliograph-
ic search. We performed a thorough literature search in 
PubMed, LILACS, Medigraphic, ELSEVIER and Cochrane. 
The upper time limit for the searches was August, 2015.
Search of other sources
The bibliographies of the included articles were 
searched, looking for additional references, and we con-
tacted the main authors of the included trials, in order to 
solve questions and complete missing information.
Data collection and analysis
The systematic review was carried out according to 
recommendations from the Cochrane Collaboration (Hig-
gins & Green, 2011). The Review Manager 5.3 (The Co-
chrane Collaboration, 2014) was used to do the analyses.
Study selection
In an independent manner, two authors read the publi-
cations which were found through the systematized search, 
in order to find the trials that fulfilled the inclusion criteria 
of this review. We put together a list of the excluded trials, 
together with reasons for exclusion. Disagreements were 
resolved through discussion and were arbitrated by a third 
and fourth author of the review, when needed. Missing in-
formation was requested from the original authors, when 
needed.
Manual searches were carried out for abstracts of the 
papers found, for their possible inclusion in the review. 
We rejected papers that were not a report of a prospec-
tive clinical trial, if they were not about couples with male 
factor and compared PICSI vs. ICSI, and if they did not 
present quantitative outcomes with respect to live births, 
clinical pregnancy, implantation, embryo quality, fertiliza-
tion and miscarriage rates.
Data extraction and management
Two reviewers, working independently, extracted 
data from each study, including them in an Excel sheet 
(search engine, title, authors, journal, years, system - 
SpermSlow, PICSI dish, others), designation of study 
(retrospective, prospective, prospective-randomized, 
other), type of study (abstract, full-text, other), type 
of intervention, inclusion criteria, exclusion criteria, ob-
jectives, results and results obtained from contact with 
authors). Differences in opinions were discussed and, 
when needed, a third person was consulted before the 
arbitrated consensus. In the case of missing data, or 
when there was a need for clarification, the study's au-
thors were contacted.
Evaluation of the risk of bias in the included 
studies
The risk of bias in the included studies was evaluated, 
using the Cochrane Risk of Bias Tool (Higgins & Green, 2011); 
this was done independently by two of the authors. Any dis-
agreement was resolved through discussion among the re-
view authors, until consensus was reached. If the information 
was not available in the published document, we contacted 
one of the authors, in order to properly evaluate the trials.
We evaluated the following types of biases: random 
sequence generation (selection bias), allocation sequence 
concealment (selection bias), blinding of participants and 
personnel (performance bias), blinding of outcome assess-
ment (detection bias), incomplete outcome data (attrition 
bias), selective outcome reporting (reporting bias) and 
other potential sources of bias. For the final risk of bias 
evaluation, we assigned values to "low risk of bias", "high 
risk of bias" or "uncertain risk of bias."
Analysis
Measuring treatment effects
In order to show the characteristics of the studies, in-
cluding their results, the information is described from the 
quantitative point of view, in order to combine the results 
of the included studies; this was done as long as they had 
similar characteristics as a function of the outcome vari-
able. The values described in each study were taken into 
account, just as they were reported by the authors of the 
original studies. In the case of missing information, we 
contacted the authors.
The following events were estimated, using odds ra-
tio (OR) as a measurement of treatment effect, with 
its respective CI of 95%: live birth, clinical pregnancy, 
implantation, embryo quality, fertilization and miscar-
riage rates. The statistical significance was established 
at a p<0.05 value. Outcome data were grouped for each 
study, using the Mantel-Haenszel (M-H) model and the 
randomized model.
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The statistical heterogeneity was quantified using the 
statistical I2 package, which shows the variation propor-
tion among the studies, with respect to total variation, that 
is, the proportion of the total variation that is attributable 
to heterogeneity (Higgins et al., 2003). To estimate the 
variance between the studies, we used the statistical Tau2 
package (Higgins & Green,2011).
All the data was analyzed using the Review Manager, 
version 5.3 statistical package (The Cochrane Collabo-
ration, 2014), recommended by the Cochrane Collab-
oration (Higgins & Green, 2011). We reported our re-
sults according to the Guidelines for the Publication of 
Systematic Reviews and Meta-Analyses of Studies that 
Evaluate Health Interventions (Directrices para la Publi-
cación de Revisiones Sistemáticas y Metaanálisis de Es-
tudios que Evalúan Intervenciones Sanitarias - PRISMA) 
(Liberati et al.,2009).
RESULTS
Description of the studies
Search results
A total of 2,918 studies were found using all search 
engines (PubMed, LILACS, Medigraphic, ELSEVIER and Co-
chrane) and an additional study was found through oth-
er sources, up to August, 2015. From these, two studies 
were included in this systematic review (Castillo-Baso & 
García-Villafaña, 2012 ; Parmegiani et al., 2010a) (Figure 
1).
Included studies
All studies that fulfilled the inclusion criteria were 
included. Two publications were included (Castillo-Ba-
so & García-Villafaña, 2012; Parmegiani et al., 2010a). 
The types of PICSI systems used by these authors were 
SpermSlow (Parmegiani et al., 2010a) and PICSI dish 
(Castillo-Baso & García-Villafaña, 2012).
From these two studies, data pertaining to a total 
of 340 women was analyzed. A total of 366 treatments 
or cycles were performed; of these, 364 cycles involved 
transfers (182 were performed using the PICSI tech-
nique, where all cycles involved transfers, and 184 us-
ing the ICSI technique, where only 182 cycles involved 
transfers).
Although practically the same objective was analyzed 
in both included studies (Castillo-Baso & García-Villa-
faña, 2012; Parmegiani et al., 2010a), Parmegiani et 
al. (2010a) divided their primary objective into three 
secondary objectives, of which only the last one was 
interesting to us, and this was the one that was taken 
into account.
Also, these authors (Parmegiani et al., 2010a) did not 
take into account sperm morphology; however, they con-
sidered these samples as having male factor due to the to-
tal number of spermatozoa and their motility. With respect 
to female patients, all were candidates for ICSI, with their 
own oocytes and fresh cycles (Castillo-Baso & García-Vil-
lafaña, 2012).
In the Castillo-Baso & Garcia-Villafaña (2012) study, 
only sperm morphology was taken into account. For our 
study's objectives, we only used, within the three de-
scribed groups of sperm morphology (≤1, 2-4% and >4% 
with KRUGER), the ≤1 and 2-4%, morphology groups, 
considering them to bear the male factor. With respect to 
female patients, all were candidates for ICSI, with their 
own oocytes and fresh cycles.
Excluded studies
All studies which did not fulfill the inclusion criteria 
were excluded. Twenty one publications were excluded for 
reasons shown in Table 1.
Risks of bias in the included studies
In Figure 2 we can see the different types of biases 
which may be present in the two papers included in this 
review; they are "risk of uncertain bias" (yellow: "'?" 
mark), "risk of low bias" (green: "+" sign) or "risk of 
high bias" (red: "-" sign). The "risk of uncertain bias" 
category is the most frequent. It is not considered to 
be a sign of bad quality of the included studies, given 
their nature. For the risk of random sequence gener-
ation (selection bias) or allocation sequence conceal-
ment (selection bias), only one study mentions being 
random, without mentioning the generation of the se-
quence and the fact that sealed envelopes were used, 
which were provided by a third party (Parmegiani et al., 
2010a). The "risk of uncertain bias" was considered for 
both included studies (Castillo-Baso & García-Villafaña, 
2012; Parmegiani et al., 2010a).
With respect to the risk of blinding participants and 
personnel (performance bias) and blinding the out-
come assessment (detection bias), none of the studies 
(Castillo-Baso & García-Villafaña, 2012; Parmegiani et 
al., 2010a) mentions blinding of the laboratory and 
medical personnel, as well as of the analysts of the 
results; we considered this to be "risk of uncertain 
bias". Thus, for the risk of incomplete outcome data 
(attrition bias), only one study shows it in its results, 
desertion of two patients, not mentioning their rea-
sons - this was considered to be a "high risk bias" 
(Parmegiani et al., 2010a). For the second study (Cas-
tillo-Baso & García-Villafaña, 2012), all patients who 
started the treatment, finished it; this was considered 
as "a low risk bias". With respect to the selective out-
come reporting bias (reporting bias), in both studies 
(Castillo-Baso & García-Villafaña, 2012; Parmegiani et 
al., 2010a) their objective was clear and they mention 
at the end whether or not it was reached; this was es-
timated as being "low risk of bias".
Finally, for other potential sources of bias, both stud-
ies bear "high risk biases" (Castillo-Baso & García-Villa-
faña, 2012; Parmegiani et al., 2010a), since one of them 
does not mention, within the described semen parame-
ters, the patients' sperm morphology (Parmegiani et al., 
2010a). In the case of the second study, that one does not 
mention sperm concentration and motility (Castillo-Baso & 
García-Villafaña, 2012).
Effects of interventions
This systematic review shows that there is no statis-
tically significant difference between both techniques, for 
none of the analyzed outcomes (Figure 3).
For the outcome pertaining to live births, the results of 
the two studies (114 events) showed no significant differ-
ence between both techniques (OR=1.31, CI 95% 0.56-
3.07, p=0.54). The I2 value was 0%, which shows "excel-
lent statistical homogeneity".
For the clinical pregnancy outcome, results from both 
studies (364 events) showed no significant difference be-
tween the two techniques (OR=1.32, CI 95% 0.82-2.13, 
p=0.25). The I2 value was 0%, which shows "excellent sta-
tistical homogeneity".
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Figure 1. Flow diagram illustrating the selection of trials included in the meta-analysis.
With respect to the implantation outcome, the results 
of the two studies (765 events) showed no significant dif-
ference between both techniques (OR=1.01, CI 95% 0.65-
1.57, p=0.95). The I2 value was 13%, which shows "low 
statistical heterogeneity".
For the fertilization outcome, the results of the two 
studies (1624 events), showed no significant difference 
between both techniques (OR=1.15, CI 95% 0.51-2.58, 
p=0.73). The I2 value was 88%, which shows "high statis-
tical heterogeneity".
For the embryo quality outcome, the results of the two 
studies (1029 events) showed no significant difference 
between both techniques (OR=1.42, CI 95% 0.95-2.12, 
p=0.09). The I2 value was 57%, which indicates "moderate 
statistical heterogeneity".
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Table 1. Excluded studies and reasons for exclusion
Author Reason for exclusion from study
Azevedo et al., 2013 Retrospective study. It is only an abstract. Does not have complete information that is needed for its analysis. Does not analyze live birth outcomes.
Barak et al., 2001 It is only an abstract. It does not have the complete information needed for its analysis. It does not analyze live birth, embryo quality and miscarriage rates.
Brassesco-Macazzaga et al., 2009 It does not analyze the live birth and miscarriage outcomes.
Castillo-Baso et al., 2011 It is only an abstract. It does not have the complete information needed for its analysis. It does not analyze the live birth and miscarriage outcomes.
Hambiliki & Bungum, 2012 It is only an abstract. It does not have the complete information needed for analysis. Does not analyze live birth, implantation and miscarriage outcomes.
Lee et al., 2013 Retrospective study. Only an abstract. It does not have the complete information needed for analyses. Does not analyze live birth outcomes.
Majumdar & Majumdar, 2013 Patients with inexplicable infertility and normozoospermic males
Menezo et al., 2010
It is only an abstract. It does not have the complete information needed for the 
analysis. Does not analyze outcomes related to live birth, fertilization and miscarriage 
rates.
Parmegiani et al., 2010b Retrospective study
Parmegiani et al., 2012 Compares two physiologic-ICSI systems: SpermSiow vs. PICSI
Santibáñez-Morales et al., 2012 Retrospective study. It does not analyze live birth, fertilization and miscarriage outcomes.
Saymé et al., 2013 Retrospective study. It is only an abstract, not having the complete information needed for analysis. It does not analyze live birth outcomes.
Van Den Bergh et al., 2009 It does not analyze live birth, implantation, embryo quality, clinical pregnancy and miscarriage outcomes.
Worrilow et al., 2005 It is only an abstract. It does not have the complete information needed for analysis. It does not analyze live birth and miscarriage outcomes.
Worrilow et al., 2006 Only an abstract. It does not have the complete information needed for analysis. It does not analyze live birth outcomes.
Worrilow et al., 2007 Is only an abstract. It does not have the complete information needed for the analysis. It does not analyze live birth outcomes
Worrilow et al., 2009 It does not analyze live birth, fertilization and miscarriage outcomes.
Worrilow et al., 2010 It does not analyze live birth and miscarriage outcomes.
Worrilow et al., 2011a It Does not analyze live birth, fertilization and miscarriage outcomes.
Worrilow et al., 2011b It does not analyze live birth and fertilization outcomes.
Worrilow et al., 2013 It does not analyze live birth and embryo quality outcomes.
With respect to the miscarriage outcome, the results 
of the two studies (94 events) showed no significant dif-
ference between PICSI vs. ICSI (OR=1.22, CI 95% 0.45-
3.27, p=0.69). The I2 value was 0%, which shows "excel-
lent statistical homogeneity".
DISCUSSION
The results of this systematic review were not statisti-
cally significant for all outcome measures. With respect to 
the risk of bias in the included studies, most of our results 
showed "uncertain risk of bias", since the randomization 
and blinding of participants is not essential, due to the 
nature of the studies. This risk was considered to be irrele-
vant, since in order to carry out the procedures, one must 
know which technique to apply and which one is adequate 
for each patient, and for this reason, we need to know the 
characteristics of the case. However, for the risk caused 
by other potential bias sources, both studies had a "high 
risk of bias," since they did not take into account sperm 
morphology, concentration and motility, which are funda-
mental parameters to determine the implementation of the 
PICSI or ICSI technique.
With respect to "statistical heterogeneity", we know 
that it only quantifies the variability between the study's 
results, and that it can be due to real differences related 
to the approach and execution of the included studies, or 
to other causes. In other words, it tries to quantify the 
variability in the results, that is measured in the different 
144Review article
JBRA Assist. Reprod. | v.22 | nº2 | Apr-May-Jun/ 2018
Figure 2. Risks of bias of the included studies.
studies, with respect to the average global outcome, and 
to determine whether this variability is higher than what 
would be expected merely by chance.
The negative values of the statistical I2 are made 
to be equal to zero, so that the I2 is between 0% and 
100%. A value of 0% shows that there is no observed 
heterogeneity and the greater values show a growing 
heterogeneity. Having markers that indicate the degrees 
of heterogeneity, 25% is considered to be "low statis-
tical heterogeneity", 50% shows "moderate statistical 
heterogeneity" and 75% implies "high statistical hetero-
geneity". These markers are attributable to the statis-
tical heterogeneity of the studies, and not to chance 
(Higgins et al., 2003). An I2 of 0% is considered to have 
"excellent statistical homogeneity" and if variability ex-
isted in the estimation of the effects, this would be due 
to sampling error in the trials, and not to heterogeneity. 
This is the case in outcomes of live births, clinical preg-
nancy and miscarriage, in our review, since the results 
do not vary more than what would be expected from 
influence by chance. Finding a "low statistical heteroge-
neity" for the implantation outcome leads us to consider 
that there is scarce variability attributable to statistical 
heterogeneity between the studies and not to chance. 
Also, for embryo quality outcomes, we found "moderate 
statistical heterogeneity", considering it to be a mod-
erate variability, attributable to the statistical hetero-
geneity between the studies and not to chance. On the 
other hand, for the fertilization outcome, we found a 
"high statistical heterogeneity", showing that the great-
est part of the variability between the studies is due to 
heterogeneity, more than chance.
In order to decrease the "statistical heterogeneity" 
in this systematic review, it is important to guarantee 
that there is no "clinical heterogeneity" that would make 
the combination of results impossible, but it is not pos-
sible to maintain a "low clinical heterogeneity" because 
few studies fulfilled our inclusion criteria; due to their 
high risk of bias, resulting in a limitation. As a conse-
quence, only two studies were included in this system-
atic review.
Our results do not show a statistically significant 
difference when comparing PICSI vs. ICSI, and these 
results coincide with those from Majumdar & Majum-
dar, 2013; Hambiliki & Bungum, 2012; Worrilow et al., 
2010. On the other hand, a statistically significant dif-
ference favors PICSI in the study by Worrilow et al. 
(2005; 2006; 2007; 2011a, 2011b; 2013). Over the 
years, these authors have studied the differences be-
tween these two techniques, with respect to diverse 
outcomes; there are variations between the studies 
concerning the following outcomes: fertilization, clinical 
pregnancy, implantation, miscarriage and embryo frag-
mentation. This coincides with Azevedo et al. (2013) 
and Lee et al. (2013), who also found statistically sig-
nificant differences when comparing PICSI vs. ICSI with 
respect to the miscarriage outcome, and to implanta-
tion and clinical pregnancy in the case of the study by 
Lee et al. (2013).
As far as we know, this is the first systematic review 
that compares PICSI vs. ICSI in the prognosis of cou-
ples with male factor, taking into account the following 
outcome measures: live births, clinical pregnancy, im-
plantation, embryo quality, fertilization and miscarriage. 
We suggest that future studies be carried out according 
to the CONSORT guidelines; however, due to the na-
ture of the intervention, it would be difficult to achieve 
blinding of the embryologist when performing the fer-
tilization technique (PICSI vs. ICSI). The risk of bias 
could be reduced in blinding for outcome analysis and 
of the personnel performing the embryo transfers. It is 
important that these future studies provide quantitative 
information on results and that the rates of miscarriag-
es, live births and clinical pregnancy be considered as 
primary results, without ignoring rates of implantation, 
fertilization and embryo quality, for the comparison of 
the techniques. We also recommend including the anal-
ysis of subgroups, in order to eliminate variables that 
affect results, such as sperm quality (morphology, con-
centration and motility), cause of female and male in-
fertility, number and quality of transferred embryos, day 
of embryo transfer, fresh or frozen transfer, own oocyte 
or donated oocyte.
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Figure 3. Effects of interventions.
CONCLUSIONS
This systematic review showed no statistically signifi-
cant difference between the PICSI and the ICSI techniques, 
for any of the studied outcome measures: live births, clin-
ical pregnancy, implantation, embryo quality, fertilization 
and miscarriage rates.
Perhaps due to the small number of clinical studies in-
cluded in this review, since few studies fulfilled our inclu-
sion criteria, due to the high risk of bias of these, it was 
not possible to prove the statistical efficacy of the PICSI 
technique over the ICSI, in couples with male factor, with 
respect to the studied outcome measures.
More clinical studies are needed, in accordance with the 
CONSORT guidelines to reduce bias risks.
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